Come up with a name for your new list and we'll add to it:
Rheos Medicines raised a round of funding on March 22, 2018. Investors include
Third Rock Ventures.
Rheos Medicines is a Cambridge, Mass.-based is a biopharmaceutical company developing medicines that modulate metabolic pathways in immune cells to treat disease. Rheos is developing a biomarker and d…